WHO Targets Meningitis-hit African Countries With New Vaccine

The World Health Organization kicked off a huge drive this week to administer a new meningitis vaccine to 300 million Africans in a swathe of countries that suffer epidemics of the deadly disease.

The campaign was launched on Monday in Burkina Faso where between 12 and 16 million people are to be vaccinated over 10 days, health officials told AFP.

Meningitis - Causes - Symptoms - Diagnosis - Treatment - FAQs
Meninges are the three layers of membrane that cover the brain and infection of the cerebrospinal fluid between them causes meningitis the disease of the meninges.

It will cover 25 sub-Saharan countries in the "meningitis belt" which stretches from Senegal in the west to Ethiopia in the east, WHO director general Margaret Chan said.

Meningitis killed 4,000 people out of 78,000 cases last year in Africa, the UN health body says.

The new MenAfriVac vaccine, produced in India, offers longer immunity against group A meningococcus, responsible for 80-85 percent of cases of meningitis in the region, and is cheaper than the one used before, the WHO says.

Brilliant Human Brain
The most amazing and complex organ in the entire universe, the human brain continues to remain an enigma.

Source-AFP

New Meningitis Vaccine Effective
A new vaccine to treat meningitis B has shown encouraging results thus far in clinical trials involving 150 babies in the UK.

New Meningitis Vaccine for Infants Shows Promise
A new vaccine, Menveo, has shown promise in clinical trials, which might help protect infants against four types of meningitis.

WHO Step Towards Meningitis Vaccine Administration in Africa